Related Experiment Video

Updated: Aug 13, 2026

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

Peptide aptamers: recent developments for cancer therapy

Corina Borghouts1, Christian Kunz, Bernd Groner

  • 1Georg-Speyer-Haus Institute for Biomedical Research, Paul-Ehrlich-Strasse 42-44, D-60596 Frankfurt am Main, Germany.

Expert Opinion on Biological Therapy
|June 15, 2005
PubMed

Insights

Peptide aptamers offer a novel approach to cancer therapy by inhibiting key signaling pathways. This review explores their isolation, delivery, and therapeutic potential in preclinical cancer models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Development

Background:

  • Significant advancements in understanding oncogenesis have identified novel signaling pathways crucial for tumor cell survival.
  • Aberrant signaling in cancer cells presents unique therapeutic targets for novel anticancer agents.

Purpose of the Study:

  • To review methods for isolating and delivering peptide aptamers.
  • To discuss the achievements and potential of peptide aptamers as cancer therapeutics.

Main Methods:

  • Selection and isolation of specific peptide aptamers targeting protein domains.
  • Strategies for modifying, stabilizing, and delivering peptide aptamers in vivo.
  • Evaluation of peptide aptamer efficacy in preclinical cancer models.

Main Results:

  • Peptide aptamers can be designed to specifically recognize and interfere with target protein functions.
  • Advances in peptide modification and delivery enhance their stability and therapeutic application.
  • Successful preclinical applications demonstrate the potential of peptide aptamers in various cancer systems.

Conclusions:

  • Peptide aptamers represent a promising class of molecules for cancer drug development.
  • Further research into their modification, delivery, and clinical application is warranted.
  • Peptide aptamers hold significant potential as novel therapeutics for cancer treatment.

More Related Videos

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes06:52

Kinetic Screening of Nuclease Activity using Nucleic Acid Probes

Published on: November 1, 2019

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...